Galectin Therapeutics GALT
NASDAQ GALT
$3.29 -0.09 (-2.66%)
At close: Nov 11, 2026 · 4:00 PM EST

Galectin Therapeutics (GALT) Notes Payables (2021 - 2026)

Updated

Galectin Therapeutics (GALT) recorded Notes Payables of $33.04 million in Q2 2026.

Analysis

Galectin Therapeutics (GALT) Notes Payables (2021 - 2026) Analysis & Trends

At the end of FY2024, Galectin Therapeutics reported Notes Payables of $21.12 million.

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,348.13 Bn 1,321.74 Bn 20.46 Bn
2 Johnson & Johnson 675.90 Bn 595.76 Bn 17.30 Bn
3 AbbVie 519.45 Bn 487.50 Bn 13.12 Bn
4 Merck 364.95 Bn 327.95 Bn 13.19 Bn
5 Novartis Ag 311.58 Bn 285.16 Bn -
6 Astrazeneca 289.34 Bn 262.94 Bn 13.26 Bn
7 Amgen 251.64 Bn 203.30 Bn 7.58 Bn
8 Gilead Sciences 212.05 Bn 187.07 Bn 6.73 Bn
9 Pfizer 167.35 Bn 115.00 Bn 12.56 Bn
10 Galectin Therapeutics 224.13 Mn 167.48 Mn -
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 33.04 Mn
Mar 31, 2026 32.88 Mn
Sep 30, 2025 32.52 Mn
Mar 31, 2025 21.28 Mn
Dec 31, 2024 21.12 Mn
Sep 30, 2024 10.52 Mn
Dec 31, 2022 29.96 Mn
Dec 31, 2021 29.05 Mn
Sep 30, 2021 19.30 Mn
API Access

Galectin Therapeutics Notes Payables API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=notes-payables&ticker=GALT&period=max&api_key=YOUR_API_KEY